This activity is expired and is no longer available for CME credit.


Systematic Review of Safety Across the Phase 2 and 3 Clinical Trials

Author(s)/Faculty: James Major, MD, PhD, FACS
Release Date: 11/6/2014Expiration Date: 11/5/2015
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider:
Dr. Major discusses the ocular and systemic safety issues encountered in the phase 2 and phase 3 aflibercept trials.